For many people, high blood pressure can be managed with medications, healthy food choices, regular exercise, and weight control.
But for a significant group of patients, these measures are not enough.
Their blood pressure remains dangerously high despite taking several medications. Doctors call this resistant hypertension, and it is one of the most difficult forms of high blood pressure to treat.
Researchers at Penn State believe they may have found a new solution.
Instead of relying on additional drugs, they have developed a soft electronic implant that communicates directly with the body’s natural blood pressure control system.
Early tests suggest the technology can significantly reduce blood pressure while avoiding many of the problems associated with current implantable devices.
The findings were published in the scientific journal Device.
High blood pressure is often called a silent condition because it usually causes no symptoms until serious damage has already occurred.
Over time, uncontrolled hypertension can harm blood vessels throughout the body and increase the risk of heart attacks, strokes, kidney failure, vision loss, and other major health problems. Because of its widespread impact, researchers continue searching for better treatment options.
One area of growing interest is bioelectronic medicine. This field uses carefully controlled electrical signals to influence the body’s own biological processes. Instead of changing body chemistry with medication, bioelectronic devices work by interacting directly with nerves and tissues.
The Penn State team focused on a natural mechanism known as the baroreflex. This system acts like the body’s built-in blood pressure regulator. Specialized sensors called baroreceptors detect changes in blood pressure and send information to the brain. The brain then adjusts heart rate and blood vessel activity to help maintain a healthy balance.
A particularly important group of these sensors is located in the carotid sinus, a small region near the carotid arteries in the neck. Because these arteries supply blood to the brain, the body closely monitors pressure in this area. Stimulating these sensors can activate signals that encourage blood pressure to fall.
Existing devices designed to stimulate the carotid sinus have shown benefits, but they are made from relatively hard materials. Human tissues are soft and flexible, while traditional implants are often made of metal and plastic.
This mismatch can cause irritation, inflammation, and tissue damage over time. The need for surgical stitches can create additional complications.
To solve these issues, the researchers designed a completely different type of implant called CaroFlex. The device is built largely from hydrogels, materials that contain large amounts of water and resemble soft biological tissues. Because of their flexibility, hydrogels can move naturally with arteries as they expand and contract during each heartbeat.
The device also includes a special adhesive hydrogel layer that allows it to stick directly to tissue. This eliminates the need for many of the stitches required by conventional implants. Researchers believe this could improve comfort and reduce tissue injury.
Laboratory testing demonstrated that CaroFlex is highly flexible and durable. It could stretch dramatically without breaking and maintained strong adhesion over extended periods. Electrical testing showed that it provided excellent contact with tissue and delivered electrical signals effectively.
The research team then moved on to animal experiments. The device was implanted near the carotid sinus of rats. By applying different electrical stimulation patterns, the researchers evaluated how effectively CaroFlex could influence blood pressure.
The results were impressive. Most stimulation settings produced meaningful reductions in blood pressure, with average decreases greater than 15%. This level of reduction could be clinically important if similar effects are eventually seen in humans.
Equally important was the device’s safety profile. Two weeks after implantation, tissues surrounding CaroFlex showed little evidence of damage or unwanted immune responses. This suggests that the soft design may solve one of the biggest challenges facing implantable bioelectronic devices.
The researchers are now working to improve the technology further and prepare for larger studies. Before human trials can begin, additional testing will be necessary to confirm long-term safety, durability, and effectiveness.
If future studies are successful, this technology could represent a major shift in how resistant hypertension is treated. Instead of adding more medications, doctors may one day use soft implants that work with the body’s own control systems to manage blood pressure.
If you care about high blood pressure, please read studies that early time-restricted eating could help improve blood pressure, and natural coconut sugar could help reduce blood pressure and artery stiffness.
For more health information, please see recent studies about added sugar in your diet linked to higher blood pressure, and results showing vitamin D could improve blood pressure in people with diabetes.
